SCHEMBL4465244

SCHEMBL4465244

CCCCCCN(CCCCCC)NCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 5/20 0.48
TSHR P16473 2/20 0.42
THRB P10828 1/20 0.42
EPHX1 P07099 3/20 0.42
GBA1 P04062 2/20 0.40
ALDH1A1 P00352 1/20 0.39
PPARA Q07869 2/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ADH1C P00326 2/20 0.38
ADH1A P07327 2/20 0.38
ADH4 P08319 2/20 0.38
S1PR2 O95136 1/20 0.38
S1PR1 P21453 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
ADH1B P00325 1/20 0.37
ADH7 P40394 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4469236 1.00 DNM1 (0.48) DNM1TSHRTHRBEPHX1GBA1
SCHEMBL2361409 0.97 DNM1 (0.43) DNM1TSHRTHRBEPHX1GBA1
SCHEMBL10627520 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1795018 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1492462 0.90 DNM1 (0.48) DNM1TSHRTHRBEPHX1GBA1
SCHEMBL15477622 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1795020 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1794183 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1794187 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1
SCHEMBL1794716 0.90 EPHX1 (0.48) DNM1TSHRTHRBEPHX1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2098316-A2 Metal nanoparticles stabilized with a bident amine Xerox Corporation (US) 2009-09-09 EP claimed
US-20090214764-A1 METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE XEROX CORPORATION (US) 2009-08-27 US claimed
US-10829442-B2 Process for the preparation of carbamates TAMINCO BVBA (BE) 2020-11-10 US disclosed
US-20190169115-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES TAMINCO BVBA (BE) 2019-06-06 US disclosed
EP-3279185-B1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES TAMINCO BVBA (BE) 2018-11-14 EP disclosed
WO-2018024828-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES TAMINCO BVBA (BE) 2018-02-08 WO disclosed
EP-3279185-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES Taminco bvba (BE) 2018-02-07 EP disclosed
EP-2098316-A2 Metal nanoparticles stabilized with a bident amine Xerox Corporation (US) 2009-09-09 EP disclosed
US-20090214764-A1 METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE XEROX CORPORATION (US) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829442-B2 Process for the preparation of carbamates CPS1, GLUL, CBR3 DNM1 3563/4885TSHR 1833/4885THRB 2545/4885
US-20190169115-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES CPS1, GLUL, C9 DNM1 3844/4885TSHR 1994/4885THRB 2482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.